<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04270188</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL20_0077</org_study_id>
    <secondary_id>2020-A00350-39</secondary_id>
    <nct_id>NCT04270188</nct_id>
  </id_info>
  <brief_title>Evolution of Symptoms After Anterior Sacrospinofixation by Autologous Tissues</brief_title>
  <acronym>SANTAU</acronym>
  <official_title>Prospective Study of the Evolution of Symptoms After Anterior Sacrospinofixation by Autologous Tissues</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prolapse is a pathology that can cause pelvic, urinary or sexual functional disorders and
      impaired quality of life. Although the use of vaginal mesh is a commonly practiced technique
      to correct prolapse, in recent years health officials have pointed to the lack of adequate
      safety and tolerability assessments of these implants. Currently, surgeons are therefore
      moving towards techniques without implants. The standard vaginal technique for the treatment
      of uterine prolapse is sacrospinofixation according to Richter. This technique can be
      performed without an implant, using autologous tissue.

      Functional discomfort of patients is the main problem linked to the presence of prolapse.
      However, no study has yet evaluated the feelings of patients following the use of this
      sacrospinofixation technique by autologous tissues by vaginal route, which led us to set up
      this study.

      The hypothesis is that the technique of anterior sacrospinofixation by autologous tissues
      improves the symptoms experienced by patients with an mid-level and / or anterior genital
      prolapse.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2020</start_date>
  <completion_date type="Anticipated">September 2024</completion_date>
  <primary_completion_date type="Anticipated">September 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>improvement of symptoms</measure>
    <time_frame>at Month 2</time_frame>
    <description>percentage of patients with symptom change on the PGI-I scale (score 1, 2, or 3)</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">66</enrollment>
  <condition>Pelvic Organ Prolapse</condition>
  <arm_group>
    <arm_group_label>anterior sacrospinofixation with autologous tissue</arm_group_label>
    <description>patients with middle and / or anterior prolapse ≥ II in the POP-Q classification and for whom an intervention by anterior sacrospinofixation by autologous tissues is planned.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>evolution of patient symptoms</intervention_name>
    <description>evolution of symptoms on the PGI-I scale (score 1, 2, or 3) 2 months after surgery</description>
    <arm_group_label>anterior sacrospinofixation with autologous tissue</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients over 18 years old with middle and / or anterior prolapse ≥ II in the POP-Q
        classification and for whom an intervention by anterior sacrospinofixation by autologous
        tissues is planned.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women over 18

          -  middle and / or anterior genital prolapse (hysterocele and / or cystocele) requiring
             surgical correction of stage ≥ II in the POP-Q classification

          -  patients wanting an intervention because of the discomfort caused by the prolapse

          -  intervention planned by anterior sacrospinofixation by autologous tissues

          -  person having expressed his non-opposition

        Exclusion Criteria:

          -  prolapse of stage &lt; II in the POP-Q classification, or prolapse without functional
             impairment

          -  disorders involving an unacceptable risk of postoperative complications sought after
             questioning of the patient (blood coagulation disorders, immune system disorders,
             progressive diseases, etc.)

          -  reduced mobility of the lower limbs (not allowing positioning for surgery)

          -  pregnancy or any pregnancy plan for the duration of the study

          -  active or latent infection

          -  inability to understand the information given

          -  person deprived of liberty, under guardianship.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Géry LAMBLIN, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospices Civils de Lyon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Géry LAMBLIN, MD</last_name>
    <phone>472 35 58 71</phone>
    <phone_ext>+33</phone_ext>
    <email>gery.lamblin@chu-lyon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospices Civils de Lyon</name>
      <address>
        <city>Bron</city>
        <zip>69500</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Géry LAMBLIN, MD</last_name>
      <phone>472 35 58 71</phone>
      <phone_ext>+33</phone_ext>
      <email>gery.lamblin@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Géry LAMBLIN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gautier CHENE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philippe Chabert, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre Jousselin de Saint Hilaire, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sophie Warembourg, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Franck Jacquot, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lucie Bonin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>February 12, 2020</study_first_submitted>
  <study_first_submitted_qc>February 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 17, 2020</study_first_posted>
  <last_update_submitted>July 20, 2020</last_update_submitted>
  <last_update_submitted_qc>July 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>middle anterior prolapse ≥ II (POP-Q classification)</keyword>
  <keyword>anterior prolapse ≥ II (POP-Q classification)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

